Xiaona Lu

415 total citations
22 papers, 252 citations indexed

About

Xiaona Lu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaona Lu has authored 22 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaona Lu's work include Cancer Mechanisms and Therapy (3 papers), Ferroptosis and cancer prognosis (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Xiaona Lu is often cited by papers focused on Cancer Mechanisms and Therapy (3 papers), Ferroptosis and cancer prognosis (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Xiaona Lu collaborates with scholars based in China, United States and Italy. Xiaona Lu's co-authors include Peng Shu, Wenjie Huang, Fang Wen, Xiaoxue Chen, Yawei Zheng, Jiani Huang, Miao Liu, Chi Ma, Zhuo Yu and Xiaodong Tan and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and Free Radical Biology and Medicine.

In The Last Decade

Xiaona Lu

21 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaona Lu China 10 132 61 61 56 34 22 252
Weijie Qiang China 8 169 1.3× 65 1.1× 69 1.1× 95 1.7× 36 1.1× 14 327
Shengjia Chen China 11 156 1.2× 71 1.2× 52 0.9× 34 0.6× 54 1.6× 26 395
Bangxiang Xie China 10 191 1.4× 93 1.5× 48 0.8× 62 1.1× 37 1.1× 22 378
Chao Meng China 9 134 1.0× 66 1.1× 88 1.4× 56 1.0× 23 0.7× 18 321
Xiaowei Meng China 10 159 1.2× 84 1.4× 61 1.0× 100 1.8× 41 1.2× 27 303
Haiyan Ma China 11 143 1.1× 47 0.8× 105 1.7× 36 0.6× 50 1.5× 11 304
Lingdan Chen China 9 109 0.8× 43 0.7× 54 0.9× 50 0.9× 48 1.4× 15 255
Zhenlei Wang China 11 174 1.3× 117 1.9× 54 0.9× 42 0.8× 44 1.3× 50 375
Zhang Li China 7 142 1.1× 52 0.9× 58 1.0× 65 1.2× 41 1.2× 52 317

Countries citing papers authored by Xiaona Lu

Since Specialization
Citations

This map shows the geographic impact of Xiaona Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaona Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaona Lu more than expected).

Fields of papers citing papers by Xiaona Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaona Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaona Lu. The network helps show where Xiaona Lu may publish in the future.

Co-authorship network of co-authors of Xiaona Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaona Lu. A scholar is included among the top collaborators of Xiaona Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaona Lu. Xiaona Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yuyao, Xiaona Lu, Weijia Du, et al.. (2025). Nanodelivery of arsenic trioxide induces macrophage-governed cGAS-STING signaling to remodel immune microenvironment in hepatocellular carcinoma. Chemical Engineering Journal. 506. 159943–159943. 3 indexed citations
2.
Lu, Xiaona, Yuyao Li, Yue Li, et al.. (2024). Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling. Phytomedicine. 126. 155395–155395. 13 indexed citations
3.
Zhang, Xuemei, et al.. (2024). Bile Acids and Liver Cancer: Molecular Mechanism and Therapeutic Prospects. Pharmaceuticals. 17(9). 1142–1142. 2 indexed citations
4.
Lu, Xiaona, K. Liu, Zuo‐Feng Zhang, et al.. (2024). Ferrochelatase Gene Variants Associated with Cholestasis in Adults: A Case Report. Journal of Clinical and Translational Hepatology. 0(0). 0–0.
5.
Lu, Xiaona, Pengyu Ni, Paola Suárez-Meade, et al.. (2024). Transcriptional determinism and stochasticity contribute to the complexity of autism-associated SHANK family genes. Cell Reports. 43(7). 114376–114376. 3 indexed citations
6.
Lu, Xiaona & Yong‐hui Jiang. (2024). Intrathecal Injection of Newborn Mouse for Genome Editing and Drug Delivery. Journal of Visualized Experiments. 1 indexed citations
7.
Zhang, Zuo‐Feng, Kun Liu, Xiaona Lu, et al.. (2024). Late-onset Cholestasis with Paucity of Portal Area Secondary to HNF1β Deficiency in Adulthood: A Case Report. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 3 indexed citations
8.
9.
Lu, Xiaona, Yuyao Li, Yue Li, et al.. (2023). Advances of multi-omics applications in hepatic precancerous lesions and hepatocellular carcinoma: The role of extracellular vesicles. Frontiers in Molecular Biosciences. 10. 1114594–1114594. 5 indexed citations
10.
11.
Wen, Fang, Xiaona Lu, Wenjie Huang, et al.. (2022). Characteristics of immunophenotypes and immunological in tumor microenvironment and analysis of immune implication of CXCR4 in gastric cancer. Scientific Reports. 12(1). 5720–5720. 15 indexed citations
12.
Guo, Ping, Shilong Han, Wendan Yu, et al.. (2022). BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A. Redox Biology. 55. 102418–102418. 11 indexed citations
13.
Li, Wenyang, Sheng Hu, Chunfang Tian, et al.. (2021). TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression. Free Radical Biology and Medicine. 177. 31–47. 7 indexed citations
14.
Lu, Xiaona, Yawei Zheng, Fang Wen, et al.. (2021). Study of the active ingredients and mechanism of Sparganii rhizoma in gastric cancer based on HPLC-Q-TOF–MS/MS and network pharmacology. Scientific Reports. 11(1). 1905–1905. 32 indexed citations
15.
Lu, Xiaona, et al.. (2021). Salvianolic acid B attenuates oxidative stress-induced injuries in enterocytes by activating Akt/GSK3β signaling and preserving mitochondrial function. European Journal of Pharmacology. 909. 174408–174408. 21 indexed citations
16.
Lu, Xiaona, Yawei Zheng, Fang Wen, Wenjie Huang, & Peng Shu. (2020). Effectiveness and Safety of Oral Chinese Patent Medicines Combined with Chemotherapy for Gastric Cancer: A Bayesian Network Meta‐Analysis. Evidence-based Complementary and Alternative Medicine. 2020(1). 8016531–8016531. 9 indexed citations
17.
Huang, Wenjie, Fang Wen, Xiaona Lu, et al.. (2020). <p>Multidrug Resistance of Gastric Cancer: The Mechanisms and Chinese Medicine Reversal Agents</p>. Cancer Management and Research. Volume 12. 12385–12394. 33 indexed citations
18.
Huang, Jiani, et al.. (2020). Identification of Hub Genes and Discovery of Promising Compounds in Gastric Cancer Based on Bioinformatics Analysis. Biomarkers in Medicine. 14(12). 1069–1084. 6 indexed citations
19.
Huang, Wenjie, et al.. (2020). Jianpi-yangwei decoction inhibits DNA damage repair in the drug resistance of gastric cancer by reducing FEN1 expression. BMC Complementary Medicine and Therapies. 20(1). 196–196. 9 indexed citations
20.
Lu, Xiaona, et al.. (2014). High-sensitivity cardiac troponin T is a predictor of recurrent acute coronary syndrome in patients with acute myocardial infarction. Genetics and Molecular Research. 13(2). 3819–3825. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weijie Qiang Breakdown of academic impact, for papers by Shengjia Chen Breakdown of academic impact, for papers by Bangxiang Xie Breakdown of academic impact, for papers by Chao Meng Breakdown of academic impact, for papers by Xiaowei Meng Breakdown of academic impact, for papers by Haiyan Ma Breakdown of academic impact, for papers by Lingdan Chen Breakdown of academic impact, for papers by Zhenlei Wang Breakdown of academic impact, for papers by Zhang Li
Rankless by CCL
2026